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Abstract
Environmental exposures have been recognized as critical in the initiation and exacerbation of 
asthma, one of the most common chronic childhood diseases. The National Institute of Allergy 
and Infectious Diseases (NIAID), National Institute of Environmental Health Sciences (NIEHS), 
National Heart, Lung, and Blood Institute (NHLBI), and Merck Childhood Asthma Network 
(MCAN) sponsored a joint workshop to discuss the current state of the science with respect to the 
indoor environment and its effects on the development and morbidity of childhood asthma. The 
workshop included U.S. and international experts with backgrounds in allergy/allergens, 
immunology, asthma, environmental health, environmental exposures and pollutants, 
epidemiology, public health, and bioinformatics. Workshop participants provided new insights into 
the biologic properties of indoor exposures, indoor exposure assessment and exposure reduction 
techniques. This informed a primary focus of the workshop-- to critically review trials and 
research relevant to the prevention or control of asthma through environmental intervention. The 
participants identified important limitations and gaps in the scientific methodologies and 
knowledge, and proposed and prioritized areas for future research. The group reviewed 
socioeconomic and structural challenges to changing environmental exposure and offered 
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recommendations for creative study design to overcome these challenges in trials to improve 
asthma management. The recommendations of this workshop can serve as guidance for future 
research in the study of the indoor environment and on environmental interventions as they pertain 
to the prevention and management of asthma and airway allergies.
Keywords
asthma; allergy; child health; indoor allergens; pollutants; environmental intervention; clinical 
trials
Introduction
Many trials aiming to improve asthma outcomes by altering the indoor environment have 
been conducted over the past two decades in response to observational studies suggesting 
that indoor environmental exposures influenced childhood asthma incidence and morbidity. 
The NIH Institutes NIAID, NIEHS and NHLBI, in collaboration with the MCAN, sponsored 
a joint workshop to discuss the current state of the science with respect to the indoor 
environment and its effects on the development and morbidity of childhood asthma. The 
workshop included US and international experts from a variety of relevant disciplines and 
addressed the unmet need to critically review environmental intervention asthma trials 
aiming at reducing asthma incidence and improving asthma control. In addition, workshop 
participants discussed indoor exposure assessment methodologies, and the biologic 
properties of allergens and indoor pollutants as they relate to the risk of asthma and asthma 
morbidity, as well as to possible protective effects that some of those exposures may have. 
This report, authored by all participants, presents the deliberations of the workshop with 
specific recommendations for current research needs in the field. The workshop was held in 
2014, but all authors contributed current updates in both recommendations and key 
publications. The authors hope that the report will stimulate the next generation of scientific 
projects and clinical trials related to the role of the environment in childhood asthma and 
respiratory allergy.
New insights into indoor exposure assessment
The indoor environment contains numerous exposures with the potential to influence asthma 
development and morbidity. Exposures include biologics (allergens, bacteria, or fungi), 
pollutant gases and particulate matter from indoor (e.g. gas stoves and cigarette smoke) and 
outdoor sources. Infiltrating ambient particulate matter contains a heterogeneous mix of 
inorganic, organic, and biologic components. (1, 2) Indoor particle sampling can include 
collection of house dust (vacuumed or swiped from surfaces) or air samples (collected 
actively or by passive settling). Experience with nasal samplers and other personal 
monitoring devices for assessment of bioaerosol inhalation exposure is limited. (3–5)
The gold standard for measurement of exposure to individual allergens in dust or air samples 
has been enzyme-linked immunosorbent assays (ELISA), which have been improved with 
reduction of assay time and use of amplification to increase sensitivity. In the past decade, 
for standardized measurement of multiple allergens in epidemiologic studies, ELISA has 
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largely been replaced by fluorescent multiplex array technology, with measurements shown 
to be reproducible within and between laboratories. (6–8) New laboratory approaches, 
advances in field sampling equipment and real-time data monitoring, including rapid tests 
for allergens (9–11) may contribute insight into the spectrum of indoor exposures (Table 1). 
(6, 7) Technologies for allergen measurement including qPCR, mass spectrometry and 
allergen biosensors are in development, including those supported by the NIH PRISMS 
(Pediatric Research using Integrated Sensor Monitoring Systems) program.(12) Mass 
spectrometry has been used as a high sensitivity method for detection of grass pollen 
allergens, and is also being evaluated for food allergen detection.(13–15) A first generation 
of allergen biosensors can measure Der p 1, Der p 2, Asp f 1 and Ara h 1, and advances in 
personal air sampling methodology have led to new insight into critical allergen exposure 
locations.(16–19)
For the characterization of indoor microbial communities in dust and air, prior to the 
availability of culture independent technology enabling metagenomics, environmental 
microbial taxa were measured either by culture, qPCR of select taxa, or quantification of 
presence or activity of bioactive indoor pathogen-associated molecular patterns (PAMPs). 
Gram negative bacteria endotoxin bioactivity has been quantified using both kinetic Limulus 
amebocyte lysate (LAL) and recombinant Factor C (rFC) assays.(20–22) Endotoxin and the 
gram positive PAMP biomarker, peptidoglycan (N-acetyl muramic acid) have been also 
measured by gas chromatography/mass spectrometry (GC/MS). These methods are now 
complemented by culture independent metagenomic characterization of communities of 
microbes originating from a multitude of sources (e. g., humans, pets, mice, cockroaches, 
dust mites, water, soil, plants, building materials).(23, 24) Amplification and sequencing of 
select regions (16S rDNA for bacteria; 18S or ITS for fungi) of ribosomal DNA (rDNA), the 
gene that encodes for ribosomal RNA, yields information on the taxonomic composition of 
the environmental microbiome.(23–32) Alternatively, rDNA microarrays can be used to 
characterize bacterial taxonomic abundance. Microarrays are less agnostic than rDNA 
sequencing, and may require larger quantities of 16S rDNA. (33) Whole genome shotgun 
sequencing of all DNA extracted from an environmental sample also yields information on 
taxonomic composition of bacteria, fungi and viruses, although depth of coverage may be 
less than for rDNA amplification and sequencing. It also provides characterization of 
potential function through metagenomics estimation of the proportion of genes detected for 
given microbial metabolic pathways.(34) All of these metagenomic techniques generate 
relative abundance data for taxonomic composition or representation of functional pathways, 
but do not measure total bacterial or fungal microbial load, a task that requires qPCR. Also, 
they do not adequately address the actual function of household bacteria, and the relevance 
to that function to metabolic products (including breakdown of household chemicals) that 
could influence human health, or to colonization of the human microbiome.
Research Priorities
• Analytical/Technological Improvements
– Personal monitoring devices for allergen, pollutant, and microbial 
exposures, including capacity for continuous monitoring, real-time data 
capture and spatial mapping
Gold et al. Page 5





















– Development of techniques for uncontaminated and unbiased 
collection, extraction and processing of environmental microbiome 
samples in air and dust
– Expansion of methods to measure environmental microbial functional 
potential and viability
– Assessment of the metabolism of household chemicals by 
environmental microbes
• Development of methods for:
– Quantification of multiple combined as well as individual indoor 
environmental allergens, microbes, pollutants, and household chemicals 
(“the exposome”)
– Assessment of their relevance to human compartmental (e.g., upper 
airway, lower airway, gut) exposures during critical life stages
Insights into biologic properties of indoor exposures and associations with respiratory 
allergy and asthma outcomes
Molecular studies of allergens, adjuvants and other environmental stimuli—
Allergy is classically manifested by an IgE antibody response to something that is normally 
considered harmless, typically a protein. The role of allergens in cross-linking pre-formed 
IgE on mast cells followed by the recruitment of Th2 cells, basophils and eosinophils and 
resulting in immediate and late allergic responses, is well understood. Given that not all 
proteins are allergenic, other biologic properties of allergens that are less understood may be 
responsible for their allergenic potential. Recent studies focus on the importance of allergen 
proteases (37) in disrupting airway epithelial barrier integrity and function and allowing for 
more effective antigen uptake by innate immune cells.(38–40) Also, non-antigenic 
stimulation of pattern recognition receptors on epithelial cells can produce alarmins like 
TSLP, IL-33, IL-25 leading to Type 2 immune response polarization. (41, 42)
Human and in-vitro laboratory studies have suggested a variety of adverse or protective 
airway responses to inhaled allergens modulated by co-exposure to natural adjuvants, (e.g. 
bacterial components) that depend on dose, timing of exposure and host characteristics. In 
some mouse models, endotoxin was found to be the primary adjuvant in common house dust 
for promoting Th17 responses and neutrophilic inflammation characteristic of steroid-
resistant asthma, but this microbial product was dispensable for priming the Th2 responses 
that are associated with allergic asthma.(43) In contrast, bacterial flagellin stimulated strong 
Th2 responses to ovalbumin, and was an important adjuvant component in some samples of 
house dust. (44) Thus, in mouse models, microbial ligands found in house dust can act in a 
dose-dependent manner to direct discrete types of immune responses to inhaled allergens.
(45, 46) Human studies support this general notion that concomitant exposure to allergens 
and microbes can shape the type of immune response to the allergen that develops. (23, 24, 
43, 44)
Gold et al. Page 6





















Allergen and microbial exposures may interact with each other and with pollutants, leading 
to harmful or, in certain cases, beneficial immunologic and clinical effects.(47, 48) Tobacco 
smoke and other inhalant toxins appear to alter epithelial cell gene expression throughout the 
respiratory tract and are likely to be important co-factors in immune response to allergens 
and perpetuation of asthma.(38) Metabolites of microbes and other organisms can also act as 
adjuvants. For example, chitin, a polysaccharide in allergens, fungi and insects, has been 
shown to be an adjuvant for Th2 responses.(45, 46, 49)
The effects of allergens, adjuvants and other environmental stimuli on the human airway 
epithelium can be studied in vitro with the use of primary cell cultures. Nasal brushing 
yielding upper airway respiratory epithelial cells from the inferior turbinate offers targeted 
opportunities for epigenetic and gene expression characterization of airway responses 
potentially relevant to asthma and allergic rhinitis.(50) While it is a minimally invasive 
procedure, nasal brushing is perceived with variable levels of comfort/discomfort by 
children and adults.(51) A recent study suggest that gene expression responses to tobacco 
smoke in the nasal epithelium correlate well with that in lower airway epithelial cells. (52, 
53)
Population level studies of allergen exposure—While the prospective relation of 
home allergen levels to allergy development has been well-studied in specific birth cohorts, 
including those with clinical trial designs (Table 3), the National Survey of Lead and 
Allergens in Housing and National Health and Nutrition Examination Survey 2005–2006 
were the first US population-level studies of cross-sectional associations between allergen 
exposures, allergic conditions and sensitization. (54, 55) These surveys indicated that almost 
half of the US population was sensitized to aeroallergens and that exposure to multiple 
allergens in homes was common. While many prospective as well as cross-sectional studies 
show adverse associations of allergens or their sources with allergic sensitization, wheeze or 
asthma, protective associations have also been found with exposures to animal allergens or 
their mammalian sources,(56–60) and in one multi-city disadvantaged urban U.S. cohort 
study, to multiple allergens including cockroaches and dust mite.(24) Collectively, these 
findings underscore the need to understand time windows of susceptibility to allergic 
sensitization and the complex dose-response relationships between allergen exposure, other 
heritable or environmental co-exposures (e.g., stress, pollutants) and sensitization.
Research Priorities
• Studies on biochemical characteristics, such as protease or lipid binding activity, 
of a wide variety of allergens, to elucidate their contribution to allergy.
• Studies of individual and combined influences of natural adjuvants, microbial 
substances, and inhaled irritants and toxicants on immune and airway responses 
relevant to allergy and asthma, using in vitro, in vivo, and human studies that 
take into account dose, timing, vulnerability and susceptibility.
• Studies of airway respiratory epithelial cell responses to environmental stimuli 
with further development of more consistently comfortable upper airway 
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sampling methods yielding outcomes relevant to the lower airways and asthma.
(50)
Exposure reduction techniques: Fundamental concepts/methods and new insights for 
environmental interventions
Air pollutants found indoors, that can trigger asthma symptoms, originate from outdoor 
(e.g., traffic) and indoor sources (e.g., secondhand smoke (SHS), gas stove emissions). 
Elimination of SHS through smoking cessation and home smoking bans should always be 
considered a first-line indoor environmental intervention for children with asthma. 
Technologic improvements have been made in the efficacy of High Efficiency Particulate 
Air (HEPA) particle filtration designed to remove targeted indoor air pollutants such as fine 
particulate matter (PM2.5).(61) Other than replacement of gas stoves with electric stoves, 
fewer methods are currently available for indoor NO2 reduction of indoor or outdoor origin.
(62, 63) In homes with smokers, recent home and school-based intervention trials in children 
report significant reductions in particulate matter with HEPA filter use, (64–66) but without 
reduction in indoor gases, without consistent reductions in markers of cigarette smoke, and 
with mixed success in improving child asthma symptoms. The efficacy in reducing indoor 
pollutants is dependent on room dimensions and building structure and conditions. While air 
cleaners have been also been used as adjunct interventions in multipronged environmental 
intervention trials (67) successful in reducing asthma symptoms, their independent 
contributions to health is uncertain, and the physical settings in which they may reduce 
exposure sufficiently to contribute to asthma control are also not well defined.
Indoor fungi originate through penetration from outdoors as well as from indoor sources, 
especially in damp and water damaged buildings.(68–70) They have a multitude of forms, 
properties and components. Fungi and their irritant or toxicant components can have adverse 
airway irritant as well as allergenic properties, and asthma symptoms can occur in 
individuals not sensitized, as well as in those sensitized to fungi.(71, 72) The mechanisms 
for effects of individual fungal components and interactive effects with other indoor 
exposures on airway and immune responses are not well-understood. Paradoxically, some 
observational birth cohort studies suggest that specific microbial communities or early life 
diversity of microbial agents, including fungi, may protect against allergy development,(73) 
but this is not a justification for discouraging fungal remediation in water damaged homes or 
poorly maintained moldy homes.
In symptomatic patients with asthma, fungal prevention and remediation strategies and their 
success in reducing exposures or improving health in damp or water damaged buildings can 
vary by housing stock, climatic region, and resident behaviors. New building materials, 
ventilation systems, and home furnishings, particularly those harboring humidity, may 
introduce new challenges requiring novel strategies to minimize fungal growth. While a 
review of studies to reduce mold in buildings and assess health outcomes recommended 
“better research, preferably with a randomized controlled study design and with more 
validated outcome measures,” (74–76) imaginative study designs are needed to fit extreme 
situations investigators and communities are at times confronted with. In disasters with 
clear-cut mold damage the health risks can be obvious, but building remediation solutions 
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may be challenging. The post-Hurricane Katrina HEAL study reported improvement of 
asthma symptoms with implementation of a hybrid intervention with asthma counselors and 
environmental remediation, but in the midst of post-disaster changes, investigators could not 
disentangle the extent to which the active study environmental interventions were 
responsible for the observed fungal reduction or symptom improvement.(77)
A variety of multi-pronged community-based strategies have been used to decrease indoor 
allergen exposures (78, 79) with varying success in reducing exposure and in improving 
asthma control. This inconsistency may be due to variable levels of intensity of the 
intervention, provided resources, participant education, social resources or adherence. More 
confounders include other changes in environmental exposures, differences in tailoring the 
interventions to individual sensitivities of the participants, baseline levels of allergens, and 
effect modification of the intervention health effect by the presence of co-exposures like 
stress or ETS (i.e., SHS).
While many studies have sampled and tested efficacy of interventions in individual indoor 
homes, effects of the structure and building components of housing, including multi-unit 
structures, on exposure are less well studied. In Northeastern and mid-Atlantic cities, asthma 
prevalence is often high in multifamily low-income housing sites where multiple and 
interrelated housing-related exposures are present. A few studies have evaluated indoor 
environmental and respiratory health before and after alterations in single or multifamily 
homes that undergo ‘green’ construction, renovation or weatherization under construction 
guidelines aimed to conserve energy while maintaining adequate ventilation, using 
“environmentally friendly” materials. Such studies take advantage of costly interventions 
already taking place but have the potential limitations of uncontrolled observational study 
designs.(80) In one Boston-based study, asthmatic children living in green homes 
experienced substantially lower risk of asthma symptoms, hospital visits, and asthma-related 
school absences than children living in conventional public housing.(80) A study of green 
housing in the South Bronx (81) showed improvements in asthma symptoms and urgent care 
visits for asthma and a Chicago-based study showed self-reported asthma symptom 
improvements.(82) However, given the variable application of “green” construction 
approaches, the potential risks of responding to financial pressures by reduction of air 
exchange or inadequate maintenance even in new buildings, and study design limitations, 
uncertainty remains about which aspects of new construction may improve asthma.
Table 2 offers a summary of selected published studies on exposure reduction and on 
associations between exposure reduction with asthma control.
Research Priorities
• Well-designed (and, if feasible, blinded and controlled) trials to test the 
conditions under which free-standing air filtration systems, structural 
interventions, and other emerging building-level interventions reduce indoor 
pollutants, allergens, and other contaminants at home or in schools. This is a 
precondition to assessing whether exposure reduction improves respiratory 
health.
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• Development of effective mold reduction strategies tailored to specific individual 
risk factors (e.g., poorly controlled asthma) and building, geographic, and 
climatic factors.
• Tailoring of multipronged strategies for indoor exposure reduction to the specific 
physical and social situations of urban families and their housing situations. 
Effective strategies may require changes in physical infrastructure, as well as in 
building management practices and occupant behavior.
• Assessment, with engagement of building management and construction 
engineers, of effects of new building approaches (including ‘green’ building) and 
building characteristics (e.g., humidity, structural integrity) on indoor exposures 
and health.
• Assessment of effects of housing policy interventions, such as housing mobility 
programs, on indoor exposures.
• For highly mobile populations or for populations with little control over the 
structure of their homes, testing of low cost interventions easily transferable from 
home to home or interventions that can be applied to any home without the need 
for structural changes.
• Development of novel technologies for particle or gas filtration (including NO2 
reduction) in home and school environments.
• With community engagement, development of interventions that can be applied 
to low-income populations with limited resources, especially those with high 
mobility.
• All environmental interventions should include cost-benefit estimations.
Indoor environmental interventions for primary prevention of asthma
Primary prevention of asthma is an enviable goal that, if achieved, could reduce the 
prevalence of the disease. Of a large number of potentially modifiable risk factors for asthma 
development identified in the literature, (104) allergen exposure is one that has attracted 
considerable attention.(105, 106) Observational epidemiologic studies have identified early 
life allergen exposures as risk factors for subsequent allergic sensitization, and early allergic 
sensitization is a major risk factor for asthma.(107) However, the concept of allergen 
avoidance for primary prevention of asthma has been challenged by investigators who argue 
that this approach is limited by a) the ubiquitous nature of aeroallergens in some ecologic 
and cultural settings; b) the dominance of genetic factors in influencing the course of 
asthma; c) the importance of early priming by other factors (microbes or microbial 
components, in utero smoking, vitamin D, etc.) or, most recently d) the benefits from early 
allergen exposure as manifested by studies in food allergy and e) the protective effect against 
wheezing of high aeroallergen exposure in the first years of life. Evidence for potential 
benefits of early exposure to allergens or their sources for allergic sensitization, wheeze or 
asthma have been reported by observational birth cohort studies including the 
Massachusetts-based Epidemiology of Home Allergens and Asthma Study (EHAAS), the 
Wisconsin Childhood Origins of Asthma Study (COAST), the Detroit Childhood Allergy 
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Study (CAS) and the Urban Environment and Childhood Asthma (URECA) Study. (24, 56, 
58, 108) Most of these observational studies report protective associations with early-life 
mammalian exposures, especially dogs and associated allergens or microbes. The URECA 
data indicated that early-life multiple exposures including cockroach and mouse are 
protective, (24) whereas EHAAS found these two exposures to be risk factors. Multiple 
differences in cofactors and exposure levels may be responsible for the contrasts in these 
observational studies.
Dust mite allergen avoidance and prevention studies—Long-term follow up in 
primary allergen prevention trials focused on house dust mite reduction vary in terms of their 
success in asthma prevention. (109) The first such study was the Isle of Wight primary 
prevention study which recruited 120 children and used a multifaceted approach to reduce 
both common food allergens and house dust mite (HDM) exposure during infancy, with 
follow-up extending to 18 years. This study has shown a consistent reduction of asthma, but 
not atopy, in the allergen avoidance group (Figure 1).(110–112) A multifaceted approach for 
infants with a family history of allergic disease was also tested in the Canadian Asthma 
Primary Prevention Study (Table 3). The intervention, which began during pregnancy, 
yielded mixed results with a significant reduction in asthma, but not atopy, at 1, 2 and 7 
years. At 15 years of age, the reduction in asthma risk was seen only in females.(113, 114) 
The Manchester Asthma and Allergy Primary Prevention Study (MAAPPS) tested the effect 
of stringent indoor allergen avoidance measures in a relatively large (n=291) randomized 
controlled trial. (115) By age 3 years HDM sensitization was more common in the 
intervention group and there was no difference between the groups in physician-diagnosed 
asthma.(116, 117) Finally, in the Prevention and Incidence of Asthma and Mite Allergy 
(PIAMA) study, 810 allergic mothers were enrolled during pregnancy and randomized to 
impermeable mattress- and pillow-covers or placebo covers. Apart from a reduction in 
asthma prevalence at age 2 years, no preventive effect on asthma or allergic sensitization up 
to 8 years was observed.(118–121)
There are a number of explanations for the inconsistent findings across studies of HDM 
allergen avoidance. It might be that only a multifaceted intervention is effective.(122) 
Another potential explanation is that the baseline mite allergen levels in the PIAMA study 
were so low that further reduction could not have significant clinical effect.(115, 123) It is 
also possible, but less likely, that genetic variations in Isle of Wight and Canadian children 
made them more receptive to allergen avoidance (124) or that genes or environmental co-
factors in the home, or outside of the home modify either the magnitude or even the 
direction of the response. Overall, interpretation of these findings is difficult because the 
relationships between the levels of allergen exposure and their biologic effects are not clear.
Other potentially modifiable environmental factors for asthma prevention—An 
explanation for protective associations with pets might be that the ecology of the home 
microbiome is affected by the presence of a pet, which in turn may influence the 
gastrointestinal microbiome of the infant.(125–127) Whether the microbial ecology of a 
child’s home is affected by outdoor microbes brought in by the pet, or by the pet’s own 
microbiome is unknown (Figure 1). The mechanisms through which this protection may 
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occur are unknown, but the role of the microbiome and its biochemical products as 
modulators of innate immune system responses that may suppress allergy is an area of 
intense focus.(24, 128) One recent animal model validated the Detroit birth cohort 
observation that pet dust could be protective against allergic responses.(129)
Asthma disproportionately affects certain ethnic groups, and patterns of allergen and 
microbial exposure vary according to socioeconomic status, area of residence, and race or 
ethnicity.(130, 131) For example, non-Hispanic Blacks and Hispanics in the US Northeast 
are more likely to be exposed to mouse and cockroach allergens (but less likely to be 
exposed to HDM, dog, and cat allergens) than non-Hispanic whites.(132) In addition, 
stressful experiences, such as home or community violence, may contribute to the high 
prevalence of asthma in these communities.(133–135) Such experiences can disturb stress 
regulation and thus adversely influence immune function and increase susceptibility to 
asthma.(136) Primary prevention studies in asthma should strive to account for relevant 
social, cultural and demographic factors, as well as for the role of diet, stress and other 
lifestyle factors. (137)
Other potentially modifiable factors such as micronutrients, antioxidants and others, which 
are not considered classic environmental pollutants, allergens, or bioaerosols, are beyond the 
scope of this article. However, such factors are being actively investigated in the context of 
asthma prevention. (138–146)
Research Priorities
• Additional observational and animal model validation studies to assess the role 
of dose, route, timing and pattern of single or multiple exposures, as well as 
genetic inheritance, in determining the relation of exposure to allergy or asthma 
development. This will optimize design of asthma prevention trials focused on 
allergen, pollutant, and microbial exposures.
• Sufficiently powered observational study of multiple early-life environmental 
influences on asthma and allergy development in diverse communities in the 
United States. The recent collaboration of U.S. birth cohorts through the NIH-
sponsored effort “Environmental Influences on Child Health Outcomes” (ECHO) 
offers a unique opportunity to achieve this goal; ECHO will facilitate 
characterization of children manifesting a variety of asthma phenotypes or 
endotypes that may be differentially influenced by indoor environmental 
exposures.(147, 148)
• Studies to identify early patterns of human microbiome and its metabolic output 
in the gastrointestinal tract, the airways and the skin that are associated with the 
development of allergic diseases, and how they are influenced by the indoor 
environment, including environmental microbes, their metabolic products, and 
their functional components.
• Randomized multifaceted environmental interventions for asthma prevention 
designed to account for each element of the intervention and for social, cultural 
and other demographic factors.
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• Randomized controlled trials (RCTs) that include primary prevention of asthma, 
through stress reduction measures tailored to ethnic and cultural diversity, and 
assessment of interactive effects of stress reduction with environmental 
interventions on asthma development.
• For each of major potentially modifiable factors,
– Identify the subpopulations that would benefit from the intervention, 
and subpopulations that might be at adverse risk, or not benefit.
– Define, develop, refine and test interventions that would be of benefit to 
most children (e.g., smoking cessation).
Indoor Environmental Interventions for Asthma Management
Although indoor environmental interventions aimed at reducing asthma morbidity have been 
more successful than those aimed at primary prevention of asthma, questions remain about 
their role in asthma management. Table 2 provides an overview of the most recent 
environmental intervention trials and highlights their findings and limitations in influencing 
exposure reduction and asthma control. Effective environmental interventions are typically 
multi-faceted, tailored to the specific exposures and sensitivities of the target subject, and 
intensive.(84, 150) Publication bias leads to less publication of unsuccessful intervention 
trials, but the few that have been published suggest that single-allergen interventions and 
low-intensity efforts are ineffective. One such negative publication (151) exemplifies the 
challenge of translating an efficacious intervention from a tightly controlled clinical trial 
setting to a broader population: when the provision of allergen-proof mattress/pillow 
encasements to adults with asthma was tested in primary care, no effect was found with this 
untailored intervention. Although the study population was adults, the notion that health 
benefits observed in tightly controlled RCTs may not easily translate to more “real-world” 
settings is applicable to environmental interventions in children, too. In addition, families 
face a number of barriers to remediating environmental exposures, including costs, 
preferences, home ownership status, life-long behavioral practices, and education. For 
example, low-income urban populations are highly mobile and have limited resources with 
which to address environmental concerns. Also, residents often do not control the structure 
of their buildings since they rent, rather than those who own their homes.
The Inner-City Asthma Study (ICAS) may be the most successful environmental 
intervention study conducted to date; the intervention was targeted at specific allergen 
reduction in asthmatic children who were both sensitized and exposed to those allergens, but 
the intervention was also multi-facetted including integrated pest management targeted to 
specific allergen sensitivities, provision of HEPA vacuum cleaners, free standing bedroom 
HEPA filter air cleaners, and allergen-impermeable mattress and pillow covers. Primary trial 
results reported in 2004 found that the environmental intervention group experienced 
significant and clinically meaningful reductions in a range of asthma outcomes compared to 
controls.(84) Benefits were seen up to 12 months after the environmental intervention and 
cost-effectiveness analysis derived a cost of $750 to $1000 per year per family to implement, 
a cost they estimated was equivalent to cost of mid-range inhaled corticosteroid and 
albuterol for a child with moderately severe asthma. This translated to almost $28 per gained 
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symptom-free day.(152) Because a multi-faceted, patient-tailored, intervention was tested in 
ICAS, and direct measures of environmental tobacco smoke exposure reduction were not 
made, it is not possible to determine the relative contribution of individual components of 
the environmental intervention and exposure reduction to the successful outcome. Notably, 
both arms of the ICAS (environmental intervention and physician feedback) were successful 
without other interaction with the health care systems, but optimally environmental control 
trials should be designed in the context of optimal access to health care, access to 
medications, and appropriate clinical asthma management.
Research Priorities
• Further define the role of environmental interventions in asthma management by 
conducting randomized, multifaceted clinical trials designed to account for each 
element of the intervention and for social, cultural and other demographic 
factors.
• Determine the most feasible, and cost- and clinically-effective approach to 
environmental interventions by conducting head-to-head comparisons of various 
forms of environmental intervention.
• Determine which environmental intervention components can be effectively 
implemented and the best approaches to implementation. Studies are needed that 
will test how to effectively implement optimal environmental control schemes 
into healthcare, public health policy, housing policy, and clinical practice.
Specific, detailed research questions for each priority area in environmental interventions for 
asthma management described above are listed in Table 4. Addressing these research 
priorities will have clear implications for how healthcare providers, public health agencies, 
healthcare systems, communities, and insurers implement and support environmental 
intervention as an integral component of asthma management.
Conclusions
With a focus on indoor allergens, microbes and pollutants, workshop participants assessed 
current methods, and prioritized new method development for measurement of indoor 
environmental exposures potentially relevant to asthma development and asthma 
management. We assessed new insights into the biologic properties of many of these 
exposures, and prioritized needs for future elucidation of these properties. We reviewed the 
state-of-knowledge of the efficacy of targeted and multi-pronged environmental 
interventions in changing environmental exposures, and the social and structural challenges 
in influencing environment interventions, with recommendations for future directions. 
Finally, we reviewed the efficacy of primary prevention trials to reduce asthma development 
by altering the indoor biologic or physical environment, and the efficacy of trials to improve 
asthma management and asthma control by improving the indoor home or school 
environment. For each covered topic, the workshop offered recommendations on research 
priorities to inform the next generation of asthma prevention or asthma management trials 
that include environmental components. There was uncertainty as to whether efforts at 
primary intervention should include a trial of changes in the indoor environment. It is 
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anticipated that the newly funded, U.S.-wide NIH-initiative Environmental Influences on 
Child Health Outcomes (ECHO) as well as complementary mechanistic studies with 
functional validation of observational findings might further inform future directions. 
Ultimately, new trials and translation of trial findings into public policy will need to take into 
account the family, social, economic and neighborhood context of participants and, for 
children with established asthma, their access to adequate health care, including appropriate 
asthma medications.
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A schematic model describing presumed relationships between the microbiome and allergic 
asthma. Adapted with permission from (153)
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